The clinical application of PIVKA-II in hepatocellular carcinoma and chronic liver diseases: A multi-center study in China.
Jun JiLijuan LiuFeifei JiangXue WenYu ZhangShengcong LiJinli LouYing WangNing LiuQiuyan GuoYongmei JiaChunfang GaoPublished in: Journal of clinical laboratory analysis (2021)
Our data indicated that PIVKA-II had satisfactory diagnostic efficiencies and could be used as a screening or surveillance biomarker in HCC high-risk population.